INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 80 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $838,181 | +31.1% | 3,981,857 | -0.3% | 0.00% | – |
| Q1 2023 | $639,180 | -78.3% | 3,994,874 | -24.8% | 0.00% | – |
| Q4 2022 | $2,949,092 | -53.3% | 5,313,679 | +0.0% | 0.00% | – |
| Q3 2022 | $6,321,000 | +89.7% | 5,311,689 | +0.8% | 0.00% | – |
| Q2 2022 | $3,332,000 | -49.5% | 5,270,916 | -8.9% | 0.00% | – |
| Q1 2022 | $6,595,000 | -49.3% | 5,785,288 | +0.0% | 0.00% | – |
| Q4 2021 | $13,013,000 | -31.5% | 5,783,433 | +4.1% | 0.00% | – |
| Q3 2021 | $19,009,000 | +45.1% | 5,558,159 | +26.8% | 0.00% | – |
| Q2 2021 | $13,105,000 | +14.5% | 4,382,805 | +23.7% | 0.00% | – |
| Q1 2021 | $11,447,000 | +131.8% | 3,544,054 | +52.1% | 0.00% | – |
| Q4 2020 | $4,939,000 | +82.5% | 2,329,941 | +0.7% | 0.00% | – |
| Q3 2020 | $2,706,000 | +29.3% | 2,312,993 | 0.0% | 0.00% | – |
| Q2 2020 | $2,093,000 | +8.0% | 2,312,993 | 0.0% | 0.00% | – |
| Q1 2020 | $1,938,000 | -12.7% | 2,312,993 | 0.0% | 0.00% | – |
| Q4 2019 | $2,220,000 | -6.8% | 2,312,993 | 0.0% | 0.00% | – |
| Q3 2019 | $2,382,000 | -42.8% | 2,312,993 | 0.0% | 0.00% | – |
| Q2 2019 | $4,163,000 | -4.3% | 2,312,993 | 0.0% | 0.00% | – |
| Q1 2019 | $4,348,000 | +72.8% | 2,312,993 | +8.5% | 0.00% | – |
| Q4 2018 | $2,516,000 | -57.5% | 2,132,248 | -2.5% | 0.00% | – |
| Q3 2018 | $5,923,000 | +42.3% | 2,185,823 | +0.3% | 0.00% | – |
| Q2 2018 | $4,163,000 | -0.1% | 2,179,655 | +9.8% | 0.00% | – |
| Q1 2018 | $4,169,000 | +8.4% | 1,985,238 | +4.8% | 0.00% | – |
| Q4 2017 | $3,846,000 | +23.1% | 1,894,919 | -19.3% | 0.00% | – |
| Q3 2017 | $3,124,000 | -57.0% | 2,348,964 | -49.2% | 0.00% | – |
| Q2 2017 | $7,265,000 | -52.2% | 4,627,645 | -1.6% | 0.00% | -100.0% |
| Q1 2017 | $15,187,000 | +205.6% | 4,701,769 | +27.7% | 0.00% | – |
| Q4 2016 | $4,969,000 | -46.0% | 3,680,641 | -37.6% | 0.00% | -100.0% |
| Q3 2016 | $9,206,000 | +4.9% | 5,902,053 | -10.5% | 0.00% | 0.0% |
| Q2 2016 | $8,773,000 | -75.2% | 6,595,749 | -1.6% | 0.00% | -50.0% |
| Q1 2016 | $35,333,000 | -27.8% | 6,704,643 | +7.6% | 0.00% | -33.3% |
| Q4 2015 | $48,912,000 | -83.0% | 6,230,812 | -64.4% | 0.00% | -72.7% |
| Q3 2015 | $287,052,000 | +380.4% | 17,507,236 | +220.8% | 0.01% | +175.0% |
| Q2 2015 | $59,751,000 | -11.4% | 5,456,663 | +13.1% | 0.00% | -20.0% |
| Q1 2015 | $67,423,000 | +14.5% | 4,822,844 | +38.4% | 0.01% | +25.0% |
| Q4 2014 | $58,863,000 | +61.0% | 3,485,017 | +28.0% | 0.00% | +33.3% |
| Q3 2014 | $36,550,000 | +6.0% | 2,723,533 | +0.7% | 0.00% | 0.0% |
| Q2 2014 | $34,465,000 | +9.1% | 2,705,287 | +1.8% | 0.00% | 0.0% |
| Q1 2014 | $31,604,000 | -9.8% | 2,657,999 | +4.7% | 0.00% | 0.0% |
| Q4 2013 | $35,052,000 | -18.3% | 2,538,194 | +3.2% | 0.00% | -25.0% |
| Q3 2013 | $42,916,000 | +10.4% | 2,459,398 | +2.8% | 0.00% | 0.0% |
| Q2 2013 | $38,884,000 | – | 2,392,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $4,017,000 | 0.19% |
| Gratus Capital, LLC | 1,117,154 | $706,000 | 0.08% |
| Bleichroeder LP | 250,000 | $158,000 | 0.03% |
| Polar Capital Holdings Plc | 5,000,000 | $3,162,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $345,000 | 0.01% |
| Ergoteles LLC | 419,652 | $265,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $157,000 | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 41,396 | $26,000 | 0.00% |
| Heritage Financial Services, LLC | 4,749 | $3,000 | 0.00% |
| Evercore Wealth Management, LLC | 143,138 | $91,000 | 0.00% |